Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutic...
Leadership
John G. Cox M.B.A.
CEO, President & Director
Erick J. Lucera C.F.A., CPA
CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer
Oxana Beskrovnaya Ph.D.
Chief Innovation Officer
Johanna Friedl-Naderer
Chief Commercial Officer
Douglas Kerr M.B.A., M.D., Ph.D.
Chief Medical Officer
Axel Wiest
Senior VP and Head of Portfolio Strategy & Operations
